Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lesinurad in Hyperuricemia with Gout
NCT00955981Phase 2Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Jul 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 2, randomised, double-blind trial of lesinurad in gout (4 arms), sponsored by Ardea Biosciences, Inc. Primary endpoint: Proportion of subjects whose serum urate (sUA) level is < 6.0 mg/dL at 28 days. Started Jul 2009; status: completed.
02
Drugs
lesinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT00955981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00955981.